In this issue:
- Immune checkpoint inhibitors suppress hepatitis C virus replication
- Long-term tenofovir alafenamide for chronic hepatitis B
- Reinfection incidence and risk among people treated for recent HCV
- Effect of HBV on the risk of pregnancy outcomes
- Point-of-care HCV RNA testing in prison
- Incidence and prevalence of HCV among men using HIV PrEP
- Effect of DAAs on melatonin level and lipid peroxidation
- Effects of DAA therapy on liver stiffness
Download PDF